New 'Off-the-Shelf' cell therapy tested in patients who have run out of options

NCT ID NCT05182073

Summary

This early-stage study tested a new, lab-made cell therapy called FT576 in patients with multiple myeloma that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatment, given alone or with an existing drug (daratumumab), could help control the cancer. The study involved 31 patients who had already tried several other therapies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • City of Hope

    Duarte, California, 91010, United States

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Levine Cancer Institute

    Charlotte, North Carolina, 28204, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Medical Oncology Hematology Consultants

    Newark, Delaware, 19713, United States

  • Oncology Hematology Care, Inc

    Cincinnati, Ohio, 45226, United States

  • Roswell Park

    Buffalo, New York, 14263, United States

  • Scri-Cbci

    Denver, Colorado, 80218, United States

  • Tennessee Oncology - Nashville

    Nashville, Tennessee, 37203, United States

  • Texas Oncology-Medical City Dallas

    Dallas, Texas, 75230, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35205, United States

  • University of Minnesota

    Saint Paul, Minnesota, 55108, United States

  • Virginia Oncology Associates

    Norfolk, Virginia, 23502, United States

  • Washington University

    St Louis, Missouri, 63130, United States

Conditions

Explore the condition pages connected to this study.